[1]BUSH NA,CHANG SM,BERGER MS.Current and future strategies for treatment of glioma[J].Neurosurg Rev,2017,40(1):1-14.
[2]CHEN Y,CHEN F,SHI ZS,et al.Clinical significance of lymphocyte to neutrophil ratio in evaluating the efficacy and prognosis of concurrent radiotherapy and chemotherapy in patients with esophageal squamous cell carcinoma[J].J Mol Diagn Ther,2022,14(7):1121-1124.
[3]齐梦洋,谷元廷,迟江瑞,等.术前中性粒细胞与淋巴细胞比值和男性乳腺癌预后的关系[J].郑州大学学报(医学版),2021,56(3):323-326.
QI MY,GU YT,CHI JR,et al.Relationship of preoperative neutrophil to lymphocyte ratio with prognosis of male breast cancer[J].Journal of Zhengzhou University(Medical Sciences),2021,56(3):323-326.
[4]周洁,王畅,房咏,等.中性粒细胞/淋巴细胞比值与小细胞肺癌放疗患者预后的关系[J].现代肿瘤医学,2022,30(12):2191-2196.
ZHOU J,WANG C,FANG Y,et al.The relationship between neutrophil/lymphocyte ratio and prognosis of small cell lung cancer patients with radiotherapy[J].Modern Oncology,2022,30(12):2191-2196.
[5]HAN QY,ZHANG X,ZHANG JG,et al.Pre-operative neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with gastric cancer[J].Int Immunopharmacol,2022,113(Pt A):109371.
[6]YANG R,WANG X,MA C,et al.Tumor-infiltrating neutrophils and peripheral neutrophil-to-lymphocyte ratio conversely predicted the prognosis of patients with non-small cell lung cancer[J].Cell Immunol,2022,379:104588.
[7]INOUE Y,FUJISHIMA M,ONO M,et al.Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer[J].Breast Cancer Res Treat,2022,196(2):341-348.
[8]WELLER M,WICK W,AIDAPE K,et al.Glioma[J].Nat Rev Dis Primers,2015,1:15017.
[9]POSTI JP,BORI M,KAUKO T,et al.Presenting symptoms of glioma in adults[J].Acta Neurol Scand,2015,131(2):88-93.
[10]GOMES DOS SANTOS A,DE CARVALHO RF,DE MORAIS ANLR,et al.Role of neutrophil-lymphocyte ratio as a predictive factor of glioma tumor grade:A systematic review[J].Crit Rev Oncol Hematol,2021,163:103372.
[11]GARCIA CR,SLONE SA,DOLECEK TA,et al.Primary central nervous system tumor treatment and survival in the United States,2004-2015[J].J Neurooncol,2019,144(1):179-191.
[12]RUFF M,KIZILBASH S,BUCKNER J.Further understanding of glioma mechanisms of pathogenesis:Implications for therapeutic development[J].Expert Rev Anticancer Ther,2020,20(5):355-363.
[13]PIERSCIANEK D,AHMADIPOUR Y,OPPONG MD,et al.Blood-based biomarkers in high grade gliomas:A systematic review[J].Mol Neurobiol,2019,56(9):6071-6079.
[14]SINGH N,BABY D,RAJGURU JP,et al.Inflammation and cancer[J].Ann Afr Med,2019,18(3):121-126.
[15]LOPES M,CARVALHO B,VAZ R,et al.Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme[J].J Neurooncol,2018,136(1):173-180.
[16]WU LY,SAXENA S,SINGH RK.Neutrophils in the tumor microenvironment[J].Adv Exp Med Biol,2020,1224:1-20.
[17]MITSUYA K,NAKASU Y,KURAKANE T,et al.Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis[J].J Neurosurg,2017,127(2):433-437.
[18]HE ZQ,DUAN H,LIN FH,et al.Pretreatment neutrophil-to-lymphocyte ratio plusalbumin-to-gamma-glutamyl transferase ratio predict the diagnosis of grade Ⅲ glioma[J].Ann Transl Med,2019,7(22):623.
[19]叶韬,盛桂凤,董益忠,等.中性粒细胞淋巴细胞比值(NLR)与晚期非小细胞肺癌一线化疗疗效及预后的关系[J].现代肿瘤医学,2021,29(12):2076-2081.
YE T,SHENG GF,DONG YZ,et al.Relationship between NLR and efficacy and prognosis of first line chemotherapy for advanced non-small cell lung cancer[J].Modern Oncology,2021,29(12):2076-2081.
[20]KOUDRIAVTSEVA T,VILLANI V,LORENZANO S,et al.Neutrophil-to-lymphocyte ratio,factor Ⅷ and antithrombin Ⅲ:Inflammatory-clotting biomarkers in glioma[J].EXCLI J,2021,20:1152-1169.
[21]WANG J,XIAO W,CHEN W,et al.Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma[J].EXCLI J,2018,17:505-512.
[22]DUAN X,YANG B,ZHAO C,et al.Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model[J].BMC Cancer,2023,23(1):432.
[23]GAN Y,ZHOU X,NIU X,et al.Neutrophil/lymphocyte ratio is an independent prognostic factor in elderly patients with high-grade gliomas[J].World Neurosurg,2019,127:e261-e267.
[24]于雪迪,佘春华,孙增峰,等.术前血液学炎性反应标志物在胶质瘤患者预后中的价值[J].肿瘤防治研究,2019,46(8):714-719.
YU XD,SHE CH,SUN ZF,et al.Predictive value of preoperative hematologic inflammatory markers in prognostic of glioma patients[J].Cancer Res Prev Treat,2019,46(8):714-719.
[25]WENG W,CHEN X,GONG S,et al.Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival[J].Neurol Res,2018,40(11):917-922.
[26]MA L,LI G,WEI M.Neutrophil-to-lymphocyte ratio and its changes are related to grade Ⅱ-Ⅳ glioma recurrence[J].Cancer Manag Res,2020,12:9429-9434.